cyclosporine and Dermatitis

cyclosporine has been researched along with Dermatitis in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.13)18.7374
1990's9 (28.13)18.2507
2000's6 (18.75)29.6817
2010's14 (43.75)24.3611
2020's2 (6.25)2.80

Authors

AuthorsStudies
Bajwa, J1
Du, Z; Li, N; Lu, C; Wu, D; Yuan, X; Zhang, M; Zhu, W1
Fixsen, E; Kheterpal, M; Patel, J; Selim, MA1
Cannon, A; Fontaine, J; Forsythe, P; King, S; Prélaud, P; Roberts, E; Seewald, W; Steffan, J1
Colombo, S; Noli, C1
Kim, CH; Kim, JY; Lee, AY1
Cena, T; Noli, C1
Kim, BS; Kim, GW; Kim, HS; Kim, JM; Kim, MB; Ko, HC; Park, MY1
Cafarchia, C; Iatta, R; Immediato, D; Otranto, D; Puttilli, MR1
Lentini, M; Schepis, C; Siragusa, M1
Nagano, Y; Nakajima, H; Nakajima, K; Sano, S; Takahashi, M; Takahashi, Y; Tarutani, M; Yamamoto, M1
Campbell, KL; Santoro, D1
Chen, W; Gao, X; Gu, P; Jiang, X; Zeng, X; Zhou, Y1
Koch, SN; Peterson, AL; Rendahl, A; Torres, SM1
Favrot, C; Forster, S; King, S; Messinger, L; Nuttall, T; Seewald, W; Steffan, J1
Brégégère, FM; Frušić-Zlotkin, M; Larush, L; Magdassi, S; Milner, Y; Neuman, R; Soroka, Y; Tivony, R; Verkhovsky, L1
Köstler, E; Nüsslein, H; Schönlebe, J; Unger, L; Weigel, K; Wollina, U1
Barcham, G; Huntley, JF; Machell, J; Mackellar, A; Meeusen, EN; Meikle, L; Pettit, D; Smith, D; van den Broek, A1
Aherne, CM; Baker, KP; Breathnach, RM; Jones, BR; McGeady, TA; Quinn, PJ1
Harada, D; Manabe, H; Takashima, Y; Tsukumo, Y1
Griffiths, CE; Harries, MJ; McMullen, E1
Gardiner, P1
Lauerma, AI; Maibach, HI1
Gijbels, MJ; HogenEsch, H; Offerman, E; van Bekkum, DW; van Hooft, J; Zurcher, C1
Horgan-Bell, C; Krafchik, B; Nadarajah, S; Roifman, C1
Kondo, S; Marshall, JS; McKenzie, RC; Oran, A; Paglia, D1
Hosoda, Y; Morimoto, Y; Noguchi, M; Sugibayasi, K; Tani, S1
BaMaung, NY; Clark, RF; Fey, TA; Gauvin, DM; Gunawardana, IW; Henry, CL; Kawai, M; Kopecka, H; Krause, R; Lane, BC; Liu, L; Luly, JR; Marsh, K; Miller, L; Mollison, KW; Or, YS; Pong, M; Rhoades, TA; Sheets, MP; Smith, ML; Trevillyan, JM; Tu, NP; Wagner, R; Wiedeman, PE; Xie, Q1
Bavandi, A; Becker, S; Meingassner, JG1
Peter, RU; Ruzicka, T1
Duell, EA; Elder, JT; Esmann, J; Fisher, GJ; Gupta, AK; Nickoloff, BJ; Talwar, HS; Voorhees, JJ1

Reviews

4 review(s) available for cyclosporine and Dermatitis

ArticleYear
Complementary, holistic, and integrative medicine: chamomile.
    Pediatrics in review, 2007, Volume: 28, Issue:4

    Topics: Chamomile; Colic; Conjunctivitis; Cyclosporine; Dermatitis; Dermatitis, Contact; Diarrhea; Dyspepsia; Female; Flowers; Herb-Drug Interactions; Humans; Infant; Lactation; Morning Sickness; Phytotherapy; Plant Extracts; Plant Preparations; Pregnancy; Warfarin

2007
Topical FK506--clinical potential or laboratory curiosity?
    Dermatology (Basel, Switzerland), 1994, Volume: 188, Issue:3

    Topics: Administration, Cutaneous; Administration, Oral; Animals; Cell Division; Clinical Trials as Topic; Cyclosporine; Dermatitis; Guinea Pigs; Humans; Keratinocytes; Lymphocyte Activation; Male; Skin Absorption; T-Lymphocytes; Tacrolimus

1994
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases.
    Current pharmaceutical design, 1998, Volume: 4, Issue:5

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis; Drug Design; Humans; Immunosuppressive Agents; Inflammation; Interleukin-2; Skin Diseases; T-Lymphocytes; Tacrolimus

1998
[Cyclosporin A in the therapy of inflammatory dermatoses].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1992, Volume: 43, Issue:11

    Topics: Behcet Syndrome; Cyclosporine; Dermatitis; Dermatitis, Atopic; Humans; Lichen Planus; Photosensitivity Disorders; Psoriasis; Pyoderma Gangrenosum; Scleroderma, Localized

1992

Trials

2 trial(s) available for cyclosporine and Dermatitis

ArticleYear
Dose tapering for ciclosporin in cats with nonflea-induced hypersensitivity dermatitis.
    Veterinary dermatology, 2013, Volume: 24, Issue:3

    Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis; Drug Administration Schedule; Hypersensitivity

2013
A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis.
    Veterinary dermatology, 2012, Volume: 23, Issue:5

    Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis; Dose-Response Relationship, Drug; Double-Blind Method; Food Hypersensitivity; Immunosuppressive Agents

2012

Other Studies

26 other study(ies) available for cyclosporine and Dermatitis

ArticleYear
Juvenile cellulitis (juvenile sterile granulomatous dermatitis and lymphadenitis) in a 9-week-old puppy treated with prednisolone-cyclosporine combination therapy.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2022, Volume: 63, Issue:3

    Topics: Animals; Cellulitis; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Lymphadenitis; Prednisolone

2022
Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2/STAT3 signal pathways.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 123

    Topics: Animals; Cell Line; Cell Proliferation; Cyclosporine; Cytokines; Dermatitis; Humans; Imiquimod; Inflammation; Janus Kinase 2; Keratinocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Models, Animal; Psoriasis; Quercetin; Receptor, Notch1; Signal Transduction; Skin; STAT3 Transcription Factor; T-Lymphocytes; Transcription Factors

2020
Resolution of Pembrolizumab-Associated Steroid-Refractory Lichenoid Dermatitis with Cyclosporine.
    The oncologist, 2019, Volume: 24, Issue:3

    Topics: Aged; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis; Dermatologic Agents; Female; Humans; Lichenoid Eruptions

2019
Ciclosporin-responsive sterile pustular dermatitides in two dogs.
    Veterinary dermatology, 2014, Volume: 25, Issue:2

    Topics: Animals; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Male; Suppuration

2014
Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis.
    European journal of pharmacology, 2015, Jun-05, Volume: 756

    Topics: Aminoquinolines; Animals; Cyclosporine; Dermatitis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucosamine; Imiquimod; Immunomodulation; Mice; Mice, Inbred C57BL; Organ Size; Psoriasis; Spleen; T-Lymphocytes, Regulatory

2015
Comparison of FEDESI and SCORFAD scoring systems for the evaluation of skin lesions in allergic cats.
    Veterinary dermatology, 2015, Volume: 26, Issue:6

    Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis; Female; Immunosuppressive Agents; Male; Pruritus; Skin

2015
Refractory sclerosing panniculitis successfully treated with cyclosporin.
    The Journal of dermatology, 2016, Volume: 43, Issue:11

    Topics: Cyclosporine; Dermatitis; Dermatologic Agents; Female; Humans; Middle Aged; Scleroderma, Localized; Skin

2016
The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
    Mycoses, 2017, Volume: 60, Issue:3

    Topics: Animals; Antifungal Agents; Cyclosporine; Dermatitis; Dermatomycoses; Dogs; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Genes, MDR; Haloperidol; Humans; Malassezia; Microbial Sensitivity Tests; Promethazine; Skin; Voriconazole

2017
Erosive lichen planus on an atypical site mimicking a factitial dermatitis.
    Acta dermato-venereologica, 2010, Volume: 90, Issue:2

    Topics: Arm; Back; Biopsy; Cyclosporine; Dermatitis; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lichen Planus; Middle Aged; Skin; Steroids; Treatment Outcome

2010
Circulating level of chemerin is upregulated in psoriasis.
    Journal of dermatological science, 2010, Volume: 60, Issue:1

    Topics: Adult; Chemokines; Chronic Disease; Cyclosporine; Dermatitis; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Intercellular Signaling Peptides and Proteins; Leptin; Male; Metabolic Syndrome; Psoriasis; Skin; Up-Regulation

2010
Use of ciclosporin in a dog with canine juvenile sterile granulomatous dermatitis and lymphadenitis.
    Veterinary dermatology, 2011, Volume: 22, Issue:3

    Topics: Animals; Cyclosporine; Dermatitis; Dermatologic Agents; Dog Diseases; Dogs; Granuloma; Lymphadenitis

2011
Gsdma3 mutation causes bulge stem cell depletion and alopecia mediated by skin inflammation.
    The American journal of pathology, 2012, Volume: 180, Issue:2

    Topics: Alopecia; Animals; Cyclosporine; Dermatitis; Dermatologic Agents; Genotype; Hair Follicle; Mice; Mice, Inbred Strains; Point Mutation; Proteins; Stem Cells

2012
Frequency of urinary tract infection in dogs with inflammatory skin disorders treated with ciclosporin alone or in combination with glucocorticoid therapy: a retrospective study.
    Veterinary dermatology, 2012, Volume: 23, Issue:3

    Topics: Animals; Cyclosporine; Dermatitis; Dermatologic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Glucocorticoids; Male; Retrospective Studies; Urinary Tract Infections

2012
Penetration and biological effects of topically applied cyclosporin A nanoparticles in a human skin organ culture inflammatory model.
    Experimental dermatology, 2012, Volume: 21, Issue:12

    Topics: Administration, Topical; Adolescent; Adult; Cell Survival; Cyclosporine; Cytokines; Dermatitis; Dermatologic Agents; Emulsions; Female; Humans; Middle Aged; Nanoparticles; Organ Culture Techniques; Psoriasis; Skin; Young Adult

2012
Interstitial granulomatous dermatitis with plaques and arthritis.
    Clinical rheumatology, 2003, Volume: 22, Issue:4-5

    Topics: Arthritis; Biopsy, Needle; Cyclosporine; Dermatitis; Female; Follow-Up Studies; Granuloma; Humans; Immunohistochemistry; Middle Aged; Plaque, Amyloid; Risk Assessment; Severity of Illness Index; Treatment Outcome

2003
The effect of immunosuppression with cyclosporin A on the development of sheep scab.
    Veterinary parasitology, 2005, Feb-28, Volume: 127, Issue:3-4

    Topics: Animals; Cyclosporine; Dermatitis; Host-Parasite Interactions; Immunosuppressive Agents; Mite Infestations; Psoroptidae; Sheep; Sheep Diseases; Time Factors

2005
Clinical, immunological and histopathological findings in a subpopulation of dogs with pododermatitis.
    Veterinary dermatology, 2005, Volume: 16, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; CD4-CD8 Ratio; Cyclosporine; Dermatitis; Dog Diseases; Dogs; Female; Foot Dermatoses; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Lymphocyte Subsets; Male; Prednisolone; Pruritus; Treatment Outcome

2005
Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
    European journal of pharmacology, 2006, Feb-17, Volume: 532, Issue:1-2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Anti-Inflammatory Agents; Cell Count; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclosporine; Cytokines; Dermatitis; Disease Models, Animal; Dose-Response Relationship, Drug; Ear, Inner; Immunoglobulin E; Immunosuppressive Agents; Lymph Nodes; Male; Mice; Mice, Inbred BALB C; Peroxidase; Phosphodiesterase Inhibitors; Picryl Chloride; Prednisolone; Rolipram; T-Lymphocytes; Time Factors; Weight Gain

2006
Pyoderma gangrenosum masquerading as dermatitis artefacta.
    Archives of dermatology, 2006, Volume: 142, Issue:11

    Topics: Adult; Breast; Cyclosporine; Dermatitis; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Pyoderma Gangrenosum

2006
A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.
    The American journal of pathology, 1993, Volume: 143, Issue:3

    Topics: Adrenal Cortex Hormones; Animals; Chronic Disease; Cyclosporine; Dermatitis; Disease Models, Animal; Immunohistochemistry; Mast Cells; Mice; Mice, Inbred C57BL; Mutation; Rodent Diseases; Skin

1993
Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality.
    Pediatrics, 1997, Volume: 99, Issue:4

    Topics: Anti-Inflammatory Agents; Child; Cyclosporine; Dermatitis; Female; Humans; Hypereosinophilic Syndrome; Immunosuppressive Agents; Prednisone

1997
[Pathogenesis and therapy of inflammatory dermatoses. Cyclosporin, an advance in the therapy of psoriasis].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1995, Volume: 46, Issue:7 Suppl

    Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatitis; Humans; Inflammation; Psoriasis

1995
Cyclosporin inhibits intercellular adhesion molecule-1 expression and reduces mast cell numbers in the asebia mouse model of chronic skin inflammation.
    The British journal of dermatology, 1997, Volume: 136, Issue:4

    Topics: Animals; Cell Count; Cyclosporine; Dermatitis; Disease Models, Animal; Gene Expression; Histamine; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Male; Mast Cells; Mice; Mice, Inbred BALB C; Phenotype; Polymerase Chain Reaction; RNA, Messenger

1997
Characteristics of spontaneous erythema appeared in hairless rats.
    Experimental animals, 1998, Volume: 47, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis; Dermatologic Agents; Dexamethasone; Disease Models, Animal; Erythema; Female; Male; Rats; Rats, Wistar

1998
Diet-induced dermatitis response of hairless rats to systemic treatment with cyclosporin A (Sandimmun), cyclosporin H and FK506.
    Experimental dermatology, 1992, Volume: 1, Issue:4

    Topics: Animals; Cyclosporine; Dermatitis; Diet; Dose-Response Relationship, Drug; Hair; Histamine; Leukocyte Count; Male; Rats; Rats, Inbred Strains; Skin; Tacrolimus

1992
Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis.
    The Journal of investigative dermatology, 1989, Volume: 93, Issue:3

    Topics: Administration, Topical; Animals; Arachidonic Acid; Arachidonic Acids; Cyclosporine; Cyclosporins; Dermatitis; Dinoprostone; Enzyme Activation; Epidermis; Hyperplasia; Interleukins; Mice; Mice, Hairless; Ornithine Decarboxylase; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Transglutaminases

1989